"ovarian hormones" trang 8 - tải miễn phí từ tailieunhanh
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
12    55    1
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells

Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
9    40    1
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b

Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
10    39    1
Diaphragmatic surgery and related complications in primary cytoreduction for advanced ovarian, tubal, and peritoneal carcinoma

Diaphragmatic surgery and related complications in primary cytoreduction for advanced ovarian, tubal, and peritoneal carcinoma
9    41    1
Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: A single institution case series and review of the literature

Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: A single institution case series and review of the literature
7    24    1
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): A case report

Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): A case report
5    53    1
GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
10    67    1
Prognostic value of systemic inflammatory markers in ovarian Cancer: A PRISMAcompliant meta-analysis and systematic review

Prognostic value of systemic inflammatory markers in ovarian Cancer: A PRISMAcompliant meta-analysis and systematic review
10    43    1
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
9    42    1
Active DNA end processing in micronuclei of ovarian cancer cells

Active DNA end processing in micronuclei of ovarian cancer cells
10    78    1
The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: A randomized cross-over pilot study

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: A randomized cross-over pilot study
10    52    1
Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOvstudy): Study protocol of a randomized controlled trial in the Netherlands

Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOvstudy): Study protocol of a randomized controlled trial in the Netherlands
7    52    1
Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico

Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico
11    67    1
Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours

Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours
10    53    1
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
12    39    1
Impact of diabetes mellitus on epithelial ovarian cancer survival

Impact of diabetes mellitus on epithelial ovarian cancer survival
6    37    1
Prognostic values of S100 family members in ovarian cancer patients

Prognostic values of S100 family members in ovarian cancer patients
14    45    1
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
9    31    1
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
11    78    1
Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1

Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1
9    28    1